31.26USD-0.06%Mkt Cap: 3.83B USDP/E: 18.07Last update: 2026-05-22
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the tr…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap3.83B USD
Enterprise Value3.07B USD
Revenue (TTM)596.96M USD
Gross Profit501.74M USD
Net Income (TTM)214.33M USD
Revenue/Share4.874 USD
Last Price31.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees182
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14888U1016
Valuation
P/E (Trailing)18.07
P/E (Forward)9.98
PEG—
EV/EBITDA10.05
EV/Revenue5.15
P/S6.41
P/B3.77
EPS (TTM)1.73
EPS (Forward)3.14
52W Range
19.0590% of range32.56
52W High32.56 USD
52W Low19.05 USD
Profitability
Gross Margin85.19%
Oper. Margin49.02%
EBITDA Margin51.23%
Profit Margin36.39%
ROE22.46%
ROA19.41%
Growth
Revenue Growth5.60%
Earnings Growth11.10%
Cash Flow & Leverage
Operating CF208.67M USD
CapEx (TTM)58.00K USD
FCF Margin28.78%
FCF Yield4.49%
Net Debt-753.18M USD
Net Debt/EBITDA-2.46
Balance Sheet
Debt/Equity0.00
Current Ratio7.10
Quick Ratio6.70
Book Value/Sh8.288 USD
Cash/Share6.176 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)33.30 USD
Target Range31.50 USD – 36.00 USD
# Analysts5
Ownership
Shares Out.122.38M
Float115.58M
Insiders5.57%
Institutions89.42%
Short Interest
Short Ratio4.3d
Short % Float7.94%
Short % Out.6.41%
Shares Short7.84M
Short (prev mo.)9.13M
Technical
SMA 5026.85 (+16.4%)
SMA 20023.39 (+33.7%)
Beta0.72
S&P 52W Chg28.31%
Avg Vol (30d)2.89M
Avg Vol (10d)3.24M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—